Roche Holding AG 2017 IR
The report outlines Roche's financial and non-financial performance for the fiscal year 2017, highlighting its commitment to sustainable healthcare and innovation. Key achievements include the successful launch of Ocrevus for multiple sclerosis and Hemlibra for haemophilia A, alongside treating 137 million patients globally. Environmentally, the company reduced its water consumption by 11% and energy consumption by 9% since 2015, earning the top ranking in the Dow Jones Sustainability Indices for the ninth consecutive year. Additionally, Roche transitioned to the new GRI Standards and expanded its Global Access Programme to improve diagnostics in lower-income countries.
Company: Roche Holding AG
Sector: Manufacturing
Country: Switzerland
Year: 2017
Type: IR
Pages: 162
Roche Holding AG
The report outlines Roche's financial and non-financial performance for the fiscal year 2017, highlighting its commitment to sustainable healthcare and innovation. Key achievements include the successful launch of Ocrevus for multiple sclerosis and Hemlibra for haemophilia A, alongside treating 137 million patients globally. Environmentally, the company reduced its water consumption by 11% and energy consumption by 9% since 2015, earning the top ranking in the Dow Jones Sustainability Indices for the ninth consecutive year. Additionally, Roche transitioned to the new GRI Standards and expanded its Global Access Programme to improve diagnostics in lower-income countries.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Women in Management
Employees